527 recalls tagged with “adult product”.
Gold Star Distribution recalls Swan White Clear Alcohol, 50% ABV, 16 oz, 12 count, nationwide. FDA enforcement cites CGMP deviations and insanitary distribution-center conditions including rodent exposure. Stop using the product now and contact the distributor or a healthcare provider for guidance.
Gold Star Distribution is recalling petroleum jelly products nationwide in the United States. The recall covers Vaseline brand products and other jelly variants distributed by Gold Star Distribution. The issue stems from CGMP deviations at the distribution center and insanitary conditions due to rodent exposure. Consumers should stop using the affected products immediately and contact the company.
Gold Star Distribution is recalling Pepto Bismol 32-count distributed nationwide after CGMP deviations and unsanitary conditions at its distribution center. The recall cites rodent exposure and unsanitary distribution practices. Consumers and healthcare providers should stop using this product immediately and contact Gold Star Distribution for guidance.
Gold Star Distribution is recalling TUMS Assorted 12-count products sold nationwide through various retailers after CGMP deviations linked to insanitary conditions and rodent exposure at the distribution center. The recall covers three SKUs: 1194A with expiry 05/27 and 1194C with expiry 03/27, plus the Assorted 12-count variant. Consumers should stop using the product immediately and contact Gold
Haleon recalled 84,764 bottles of parodontax Mouthwash on December 26, 2025. The product may have missing or illegible lot and expiration dates. Consumers should stop using the mouthwash immediately.
Gold Star Distribution is recalling Tylenol products distributed nationwide. The recall concerns CGMP deviations and insanitary conditions at the distributor’s facility. Consumers should stop using these Tylenol products immediately and contact Gold Star Distribution for guidance.
Gold Star Distribution recalls Excedrin Migraine 2's, 25-count bottles distributed nationwide in the United States. CGMP deviations involve insanitary conditions including rodent exposure in the distribution center. Consumers and healthcare providers should stop using the product immediately and contact Gold Star Distribution or their healthcare provider for guidance.
Gold Star Distribution Inc. issued a nationwide recall of Colgate and Crest toothpaste on December 26, 2025 after inspectors found insanitary conditions and rodent exposure at its distribution center. The issue stems from CGMP deviations that could contaminate products. Consumers should stop using the affected toothpaste immediately and contact Gold Star Distribution for guidance.
Gold Star Distribution recalled Advil Ibuprofen Dispenser Pack distributed nationwide after CGMP deviations and rodent exposure at its distribution center. The recall covers two formats with UPCs 305730154895 and 305730164559. Consumers should stop using the product and contact the distributor or their healthcare provider for guidance.
GOLD STAR DISTRIBUTION recalls LIQUID NYQUIL regular and cherry 12/8oz bottles nationwide in the United States. The recall cites CGMP deviations and insanitary conditions including rodent exposure at the distribution center. Consumers should stop using the product immediately and contact Gold Star Distribution Inc for guidance on refunds or replacements.
Zimmer Surgical recalled 51 A.T.S. 3200TS Tourniquet Systems on December 24, 2025, due to a malfunctioning user interface. The device may freeze or become unresponsive in non-English language settings, risking delays in emergency situations. Healthcare providers should stop using the device immediately and follow recall instructions.
Medline Industries, LP recalled 141,971 suction catheter kits on December 24, 2025. The kits may contain a smaller catheter that can lead to serious respiratory issues. Health providers and patients must stop using the kits immediately to prevent potential harm.
B.C. Williams Bakery Service recalled 720 bags of Bread and Roll Mix on December 23, 2025. The recall stems from the undeclared milk allergen, posing a high risk to consumers. The affected products were distributed nationwide.
Willy Pete's Chocolates recalled 54 units of Almond Despair dark chocolate on December 22, 2025. The product contains undeclared almonds which pose a risk to consumers with nut allergies. Customers should stop using the product and seek a refund or replacement.
HANDELNINE GLOBAL recalled Rheumacare capsules on December 22, 2025, after discovering lead contamination. The recall affects four bottles of 30 capsules each distributed in New York. Consumers should stop using the product immediately and contact their healthcare provider.
Fran's Chocolates recalled 112 units of its Almondmilk Chocolate on December 20, 2025. The product may contain undeclared hazelnuts, posing a serious risk to consumers with nut allergies. The recall affects products distributed in Colorado, Massachusetts, Nevada, Washington, and online.
Boston Scientific recalled 59 AXIOS Stents on December 19, 2025. Increased reports of deployment and expansion issues pose serious risks during procedures. Users should stop using the devices immediately and follow recall instructions.
ICU Medical has recalled over 14 million needle-free access devices after reports of fluid leaks and potential exposure to biological contaminants. The recall affects devices distributed worldwide, including in 50 states and multiple countries. Users must stop using these devices immediately and follow recall instructions from the manufacturer.
MicroPort Orthopedics recalled 91 units of the HIPTURN Fem Head Trial 36mm Reusable device on December 19, 2025. The recall follows the lack of FDA premarket authorization for distribution in the United States. The affected devices were distributed across multiple states and several countries, posing a potential health risk to patients and healthcare providers.
Sato Pharmaceutical Co., Ltd. recalled 3,640 bottles of INON ACE Antacid tablets on December 19, 2025. The recall follows failed disintegration specifications, indicating the tablets may not dissolve properly. Consumers should stop using the product immediately and seek guidance from healthcare providers.